Author Correction: Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes.

Grewal, Ramandip; Nguyen, Lena; Buchan, Sarah A; Wilson, Sarah E; Nasreen, Sharifa; Austin, Peter C; Brown, Kevin A; Fell, Deshayne B; Gubbay, Jonathan B; Schwartz, Kevin L; Tadrous, Mina; Wilson, Kumanan; Kwong, Jeffrey C

Grewal, Ramandip; Nguyen, Lena; Buchan, Sarah A; Wilson, Sarah E; Nasreen, Sharifa; Austin, Peter C; Brown, Kevin A; Fell, Deshayne B; Gubbay, Jonathan B; Schwartz, Kevin L; Tadrous, Mina; Wilson, Kumanan; Kwong, Jeffrey C.

Grewal R; Public Health Ontario, Toronto, ON, Canada.
Nguyen L; ICES, Toronto, ON, Canada.
Buchan SA; Public Health Ontario, Toronto, ON, Canada.
Wilson SE; ICES, Toronto, ON, Canada.
Nasreen S; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Austin PC; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, ON, Canada.
Brown KA; Public Health Ontario, Toronto, ON, Canada.
Fell DB; ICES, Toronto, ON, Canada.
Gubbay JB; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Schwartz KL; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, ON, Canada.
Tadrous M; ICES, Toronto, ON, Canada.
Wilson K; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Kwong JC; ICES, Toronto, ON, Canada.

Nat Commun ; 14(1): 2031, 2023 Apr 11.

Artículo en Inglés | MEDLINE | ID: covidwho-2295820

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Tipo de estudio: Estudio experimental Tópicos: Vacunas / Variantes Idioma: Inglés Revista: Nat Commun Asunto de la revista: Biologia / Ciencia Año: 2023 Tipo del documento: Artículo País de afiliación: S41467-023-37906-x

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google